FDA Gives Defibtech Clearance to Market AEDs
GUILFORD, CT– June 19, 2002 – The U.S. Food and Drug Administration (FDA) has granted Defibtech LLC 510(k) clearance to market its new line of Automated External Defibrillators (AEDs). Defibtech's AEDs will be marketed under the Lifeline and Reviver names. These products were developed by a team of physicians and engineers with extensive experience not only in the medical device field, but also in high-volume consumer products. Defibtech's AEDs integrate the latest electronic technology in a package with best-in-class features and at a revolutionary price.
Standard features include: biphasic defibrillation technology, self-testing capability, class leading user interface and voice prompts, longest operational battery life (up to 7 years), and a professional-grade rugged design. Even with this industry leading feature set, the Defibtech AED is the value leader with a Manufacturer's Suggested Retail Price (MSRP) at $1,495. This price includes everything a customer needs to completely deploy this lifesaving solution, including the AED, defibrillation pads and a 5-year 125-shock battery pack.
About Defibtech
Defibtech relentlessly pursues one goal: making the best automatic external defibrillators (AEDs) in the world at affordable prices. Defibtech designs and manufactures the FDA-cleared Lifeline™ and ReviveR™ brand AEDs and related accessories. Defibtech's products are sold through its network of distribution partners in the United States and around the world. Founded in 1999, Defibtech is headquartered in Guilford, Connecticut and manufactures all of its defibrillators in the United States in state-of-the-art ISO 13485:2003 certified facilities. For more information about Defibtech and its products, visit www.defibtech.com or call 1-866-DEFIB-4-U (1-866-333-4248).
Contact
Defibtech, LLC
Greg Slusser
Vice President, Sales & Marketing
866-333-5641
greg@defibtech.com
or Defibtech Sales:
866-333-4248
sales@defibtech.com
|
